Maryam Valapour, MD, MPP
Additional Locations
Transplantation Center
Cleveland Clinic Main Campus
9500 Euclid Avenue
Cleveland, OH 44195
Directions
- Appointment:
- 216.444.6503
- Fax:
- 216.636.6329
Insurance
Is Cleveland Clinic Part of Your Insurance?
Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.
View All PlansAbout Maryam Valapour, MD, MPP
Dr. Valapour is Director of Lung Transplant Outcomes at the Cleveland Clinic.
A practicing pulmonologist and physician-scientist, she has worked in the field of lung transplantation for 22 years, contributing extensive clinical and research expertise to the field.
Her research efforts are focused on improving the U.S. transplant system and lung transplant patient outcomes. She holds an R01 award from the National Institutes of Health to develop methodologies for assessing disease progression in lung transplant candidates, determining optimal transplant timing to maximize survival, and evaluating the effects of different organ allocation strategies on individual and population survival rates.
As Principal Investigator for the Coordinating Center of the Cystic Fibrosis Lung Transplant Consortium (CFLTC), Dr. Valapour leads a collaborative network of 15 North American institutions dedicated to studying chronic transplant rejection and developing new therapies to enhance lung transplant outcomes. She also serves as Principal Investigator for the Cleveland Clinic within this consortium.
In addition to her role at the Cleveland Clinic, Dr. Valapour holds the singular role of Senior Staff for Lung Transplantation at the U.S. Scientific Registry of Transplant Recipients (SRTR), where she oversees analysis of U.S. lung transplant data and refinement of the lung allocation system. She also acts as scientific advisor to the U.S. Organ Procurement and Transplantation Network (OPTN) Lung Committee.
Dr. Valapour earned her medical degree from the Medical University of South Carolina and completed her Internal Medicine residency at Thomas Jefferson University. She further advanced her training with a fellowship in Pulmonary and Critical Care Medicine at Johns Hopkins University, where she also completed a fellowship in Bioethics and Health Policy. She also holds a master’s in public policy from the Humphrey School of Public Affairs at the University of Minnesota.
Education & Professional Highlights
Appointed
2014
Education & Fellowships
Graduate School - University of Minnesota
Master of Public Policy
Minneapolis,
MN
2011
Fellowship - Johns Hopkins University
Pulmonary/Critical Care Medicine
Baltimore,
MD
2002
Fellowship - Johns Hopkins University
Bioethics/Health Policy
Baltimore,
MD
2001
Residency - Thomas Jefferson University Medical College
Internal Medicine
Philadelphia,
PA
1998
Medical Education - Medical University of South Carolina
Charleston,
SC
1995
Undergraduate - Charleston Southern University
Charleston,
SC
1988
Additional Training
- Fellowship, Pulmonary and Critical Care (Johns Hopkins University)
- Fellowship, Bioethics and Health Policy (Johns Hopkins University)
- Master of Public Policy (University of Minnesota)
Professional Highlights
- Senior Investigator for Lung Transplantation, Scientific Registry of Transplant Recipients (SRTR), Health Resources and Services Administration (2010-present)
- Invited Expert and Reviewer for the National Academy of Science, Engineering and Medicine (NASEM) report "Realizing the Promise of Equity in the Organ Transplantation System (2022)
- Member Board of Trustees, Ohio Solid Organ Transplantation Consortium (2021 - 2023)
- A lead author for the 24 international panel of experts for the “International Society for Heart and Lung Transplantation Consensus Document for the Selection of Lung Transplant Candidates: An Update from the International Society for Heart and Lung Transplantation
- Elected Member of Executive Committee, American Society of Transplantation (AST) Thoracic and Critical Care Community of Practice (2016-2018)
- Chair, Research Committee of LifeSource Upper Midwest Organ Procurement Organization (2007-2014)
Certifications
- Internal Medicine - Pulmonary Disease
Specialty Interests
Lung Transplant
Awards & Honors
- Fellow, American Society of Transplantation
- Fellow, American College of Chest Physicians
- University of Minnesota Champion of Care award for excellence in care of patients
Memberships
- International Society of Heart and Lung Transplantation
- American Society of Transplantation
- American Thoracic Society
Research & Publications
See publications for Maryam Valapour, MD, MPP.
(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 2/14/2024, Dr. Valapour has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.
